Mackenzie Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 16-07-2024
- Paid Up Capital ₹ 1.00 Cr
as on 16-07-2024
- Company Age 12 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 33.70%
(FY 2023)
- Profit -21.17%
(FY 2023)
- Ebitda 183.82%
(FY 2023)
- Net Worth -12.85%
(FY 2023)
- Total Assets 6.86%
(FY 2023)
About Mackenzie Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vijay Agarwal, Ajay Singh, and Asha Singh serve as directors at the Company.
- CIN/LLPIN
U24240WB2012PTC183671
- Company No.
183671
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Jul 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Mackenzie Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijay Agarwal  | Director | 01-Aug-2018 | Current |
| Ajay Singh | Director | 12-Jul-2012 | Current |
| Asha Singh | Director | 12-Jul-2012 | Current |
Financial Performance and Corporate Structure Insights of Mackenzie Pharmaceuticals.
Mackenzie Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 33.7% increase. The company also saw a substantial fall in profitability, with a 21.17% decrease in profit. The company's net worth observed a substantial decline by a decrease of 12.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mackenzie Pharmaceuticals?
In 2023, Mackenzie Pharmaceuticals had a promoter holding of 98.33% and a public holding of 1.67%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mackenzie Pharmaceuticals?
Mackenzie Pharmaceuticals has a workforce of 79 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mackenzie Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mackenzie Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
